Dr. Edward J. Benz, Jr., MD, former president and CEO of Dana-Farber Cancer Institute talks about Dana Farber’s role in healthcare innovation and how this large institute interfaces with the advances and boundaries in science, public policy, philanthropy and industry. Dr. Benz explores the impediments to the effective translation of scientific advances for the public and how organizations can both successfully traverse these boundaries and exploit their synergies.